Healthcare - Biotechnology - NASDAQ - US
$ 0.9915
-1.83 %
$ 41.1 M
Market Cap
-0.63
P/E
BALANCE SHEET
116 M
ASSETS
9.44 M
LIABILITIES
106 M
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
Rallybio Corporation
| Current Assets | 115 M |
| Cash & Short-Term Investments | 110 M |
| Receivables | 0 |
| Other Current Assets | 4.86 M |
| Non-Current Assets | 831 K |
| Long-Term Investments | 239 K |
| PP&E | 592 K |
| Other Non-Current Assets | 0 |
| Current Liabilities | 9.26 M |
| Accounts Payable | 976 K |
| Short-Term Debt | 438 K |
| Other Current Liabilities | 7.85 M |
| Non-Current Liabilities | 173 K |
| Long-Term Debt | 346 K |
| Other Non-Current Liabilities | -173 K |
Balance Sheet
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | |
|---|---|---|---|---|---|
| ASSETS | |||||
| Cash & Cash Equivalents | 24.5 | 57.0 | 175.3 | 140.2 | 19.5 |
| Short Term Investments | 85.4 | 112.0 | 0 | 0 | 0 |
| Receivables | 0 | 0 | 0 | 0 | 0 |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 7.7 | 20.0 | 10.7 | 2.1 | 2.9 |
| Total Current Assets | 114.8 | 179.5 | 180.9 | 141.3 | 20.9 |
| PP&E | 0.6 | 0.9 | 0.5 | 0.3 | 0.2 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments | 0.2 | 30 K | 0.8 | 0.3 | 0.5 |
| Other Long Term Assets | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 115.6 | 180.4 | 182.2 | 141.9 | 21.6 |
| LIABILITIES | |||||
| Accounts Payable | 1.0 | 1.1 | 0.6 | 1.6 | 0.9 |
| Short Term Debt | 0.4 | 0.4 | 0 | 0 | 0 |
| Other Current Liabilities | 7.8 | 9.3 | 5.9 | 4.3 | 2.9 |
| Total Current Liabilities | 9.3 | 10.7 | 6.6 | 5.8 | 3.8 |
| Long Term Debt | 0.3 | 0.7 | 0 | 0 | 0 |
| Deferred Tax Income | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities | (0.2) | (0.4) | 32 K | 182.0 | 38.1 |
| Total Liabilities | 9.4 | 11.1 | 6.6 | 187.9 | 41.9 |
| EQUITY | |||||
| Common Stock | 4 K | 4 K | 3 K | 1.0 | 0.3 |
| Retained Earnings | (235.2) | (160.7) | (94.0) | (47.0) | (20.6) |
| Other Accumulative Comprehensive Income/Loss | 15 K | (0.2) | 0 | (230.0) | (58.0) |
| Total Equity | 106.2 | 169.3 | 175.6 | (47.0) | (20.6) |
| Total Liabilities and Equity | 115.6 | 180.4 | 182.2 | 187.9 | 41.9 |
| SHARES OUTSTANDING | |||||
| Common Shares Outstanding | 40.4 | 31.8 | 32.1 | 32.1 | 32.1 |